CONTEXT: Dr. Markus Schwaiger and colleagues at the Technical University of Munich, Germany, have demonstrated that successful transfer of the vascular endothelial growth factor (VEGF) gene results in an increase of tissue perfusion without impairing cardiac contractile function or morphology.
RESULTS: Four pigs were injected with an adenoviral vector (Ad4tk) that transferred the therapeutic VEGF gene and the PET reporter gene HSV1-tk (herpes simplex virus type 1 thymidine kinase) into their myocardia. An adenovirus expressing only HSV1-tk or VEGF in separate regions was also administered. The animals were scanned with fluorine-18 FDG-PET/CT two days later. Uptake indicated successful gene transfer. Myocardial perfusion increased in VEGF-treated areas. CT revealed no abnormalities in cardiac contractile function. F-18 galacto-RDG PET/CT performed on one animal three days after gene transfer and on another seven days after transfer showed no significant uptake in VEGF-treated regions, indicating an absence of elevated av-integrin expression associated with angiogenesis. Schwaiger and coinvestigator Frank Bengel suspect that the effect of VEGF on vasodilation and microvascular permeability restricts integrin expression.
IMAGE: Molecular PET/CT of pig heart. Left ventricular short-axis images of heart two days after gene transfer by direct intramyocardial adenovirus injection. The injection site is marked by a titanium clip, as depicted on the multislice CT image (top). The corresponding PET image (bottom) shows regional accumulation of a reporter probe, indicating successful transfer and expression of a reporter gene. A fusion image (middle) confirms colocalization of gene expression and clip-marked injection site.
IMPLICATIONS: This PET-CT technique will enable researchers to understand the genomic/proteomic changes, physiological effects, and morphologic alterations associated with cardiac gene therapy, according to Bengel. Refinements will permit them to monitor protein expression for weeks rather than days.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.